DNA analytics startup Bluebee from Delft today announced it has raised a 10 million euro series A round from Belgian investors Capricorn ICT Arkiv, Korys and Biover II. Existing shareholders also participated in the financing.
In 2015 Bluebee received 3.6 million euro, in rounds led by the international VC Buysse & Partners.
Bluebee was founded in 2011 as a spin-off from the Delft University of Technology (TU Delft) and the Imperial College London. It offers a cloud-based platform for the rapid analysis of genetic information.
According to the release, the investment will be used to further develop the platform, as it saw a quick rise in customers since Bluebee’s market introduction in 2014.
ICT and healthcare
Hans Cobben, CEO of Bluebee: “The time is right to shift gears. This funding will significantly boost our capacity to support our growth.”
Marc Lambrechts, Senior Investment Manager at Capricorn Venture Partners, added: “We appreciate the strong, interdisciplinary team at Bluebee and the complementary skills of the teams in Delft, The Netherlands and Mechelen, Belgium. In digital healthcare the key to success is the integration of know-how from the ICT world into the healthcare space.”